FMS FY 2007 Earnings Report — Fresenius Medical Care AG & Co. KGaA Revenue & Financial Results | Market Cap Arena

Fresenius Medical Care AG & Co. KGaAFMS

FY 2007 Earnings

Reported February 21, 2008

Quarter Comparison

Revenue

Operating Income

Gross Margin

Net Margin

EPS (Diluted)

Free Cash Flow

Metric	FY 2007	Prior Q	FY 2006	QoQ Change	YoY Change
Revenue	$7.8B	—	$7.5B	—	3.5%
Op. Income	$1.3B	—	$1.2B	—	8.5%
Gross Margin	34.5%	—	33.9%	—	0.7pp
Net Margin	7.4%	—	6.3%	—	1.1pp
EPS (Diluted)	$0.97	—	$0.81	—	20.3%
Free Cash Flow	$497M	—	$390M	—	27.4%

Revenue Flow

Item	Amount
REVENUE	$7.8B
Cost of Revenue	$5.1B
GROSS PROFIT	$2.7B
R&D Expenses	$53M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$1.4B
Cost & Expenses	$6.5B
OPERATING INCOME	$1.3B
Interest Income	$23M
Interest Expense	$320M
Other Income/Expenses	-$298M
INCOME BEFORE TAX	$970M
Income Tax Expense	$373M
Net Income from Continuing Ops	$606M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$575M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$575M
D&A	$291M
EBIT	$1.3B
EBITDA	$1.6B
EPS	$1
EPS Diluted	$1

Income Statement

Item	Amount
REVENUE	$7.8B
Cost of Revenue	$5.1B
GROSS PROFIT	$2.7B
R&D Expenses	$53M
Selling & Marketing	$0
General & Administrative	$0
SG&A Expenses	$1.4B
Other Expenses	$0
Operating Expenses	$1.4B
Cost & Expenses	$6.5B
OPERATING INCOME	$1.3B
Interest Income	$23M
Interest Expense	$320M
Other Income/Expenses	-$298M
INCOME BEFORE TAX	$970M
Income Tax Expense	$373M
Net Income from Continuing Ops	$606M
Net Income from Discontinued Ops	$0
Other Adjustments	$0
NET INCOME	$575M
Net Income Deductions	$0
BOTTOM LINE NET INCOME	$575M
D&A	$291M
EBIT	$1.3B
EBITDA	$1.6B
EPS	$1
EPS Diluted	$1

Cash Flow Statement

Item	Amount
Net Income	$575M
Depreciation & Amortization	$291M
Stock-Based Compensation	$0
Deferred Income Tax	$943.8K
Other Non-Cash Items	$19M
Change in Working Capital	$38M
OPERATING CASH FLOW	$962M
Capital Expenditure	-$465M
Acquisitions (Net)	-$207M
Purchases of Investments	$0
Sales/Maturities of Investments	$0
Other Investing Activities	$49M
NET CASH FROM INVESTING	-$623M
Net Debt Issuance	$14M
Common Stock Repurchased	-$6M
Common Dividends Paid	-$151M
Other Financing Activities	-$167M
NET CASH FROM FINANCING	-$273M
FREE CASH FLOW	$497M
Net Change in Cash	$69M

Balance Sheet

Item	Amount
Cash & Equivalents	$196M
Short-Term Investments	$0
Net Receivables	$1.7B
Inventory	$510M
Other Current Assets	$286M
TOTAL CURRENT ASSETS	$3.1B
PP&E (Net)	$1.6B
Goodwill	$5.8B
Intangible Assets	$553M
Long-Term Investments	$0
Tax Assets	$67M
Other Non-Current Assets	$191M
TOTAL NON-CURRENT ASSETS	$8.3B
TOTAL ASSETS	$11.4B
Account Payables	$265M
Short-Term Debt	$244M
Deferred Revenue	$0
Other Current Liabilities	$555M
TOTAL CURRENT LIABILITIES	$2.4B
Long-Term Debt	$3.2B
Deferred Revenue NC	$0
Deferred Tax Liabilities	$304M
Other Non-Current Liabilities	$951M
TOTAL NON-CURRENT LIABILITIES	$4.5B
TOTAL LIABILITIES	$6.9B
Common Stock	$0
Additional Paid-In Capital	$2.9B
Retained Earnings	$1.5B
Treasury Stock	$0
Accum. Other Comp. Income	$81M
Other Equity	$0
TOTAL STOCKHOLDERS' EQUITY	$4.5B
Minority Interest	$85M
TOTAL EQUITY	$4.5B
TOTAL LIABILITIES & EQUITY	$11.4B
Total Debt	$3.5B
Net Debt	$3.3B